Stock GENFIT (FR0004163111)
Sector : Pharmaceuticals & Biotechnology – Indices : CAC ALL-TRADABLE, CAC ALL SHARES
Last update : 24/04/2026 at 17:35:10 – Source: Euronext
Market summary
As of 24/04/2026, stock GENFIT trades at 8,18 € , with a change of -0,24 % , and a market cap of 410 M€.
Price and moving averages
Technical analysis GENFIT
| 50-day moving average8,56 €-4.44 % (below) | Pivot8,24 € |
|---|---|
| Support level7,45 €-8.92 % | Resistance level9,35 €+14.30 % |
| 1-month volatility14,01 % | Annualised volatility48,52 % |
| RSI (14d)44 Neutral | Stochastic signal (14d)Neutre |
| ATR (14d)0,55 Moderate volatility | CMF (21d)-0,04 Weak selling pressure |
| Bollinger bands (20d) Neutral | OBV (21d) Neutral (OBV stable) |
Recent news — GENFIT
GENFIT recorded a revenue of €65.4 million in 2025, boosted by royalties from Iqirvo (€21.8 million) and two milestone payments (€43.6 million) linked…
GENFIT announces that the U.S. Food and Drug Administration has granted Orphan Drug Designation (ODD) to G1090N (nitazoxanide), its experimental candi…
Genfit has received orphan drug designation from the FDA for NTZ in the treatment of acute hepatic failure on cirrhosis (ACLF). This designation, anno…
GENFIT saw an increase of 3.53% this Thursday morning, reaching 8.94 euros, bringing its quarterly performance to over 84%. The stock of the biopharma…
Latest earnings
| Annuels 2025 | |
|---|---|
| Revenue |
71 M€
+0,2 % |
| EBITDA | -26 M€ |
| EPS (diluted) | -0,78 € |
| Free cash flow | 2 M€ |
| Net debt | 31 M€ |
Analyses on GENFIT stock
No analysis has been published on this stock yet.
Frequently asked questions about GENFIT stock
What does the recent price action of GENFIT stock show?
GENFIT stock is currently trading around 8,18 €, down 0,24% and down 0,10% over one week.
Is GENFIT stock in a support or resistance zone?
Technical levels help place the stock. Support: 7,45 €. Resistance: 9,35 €.
How should the current volatility of GENFIT stock be interpreted?
Volatility is around 48,52%.
